Reimbursement

Top articles of the week from Specialty Pharmacy Times.

Health care has historically been physician-patient focused, but pharmacists and patients are changing this trend.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses trends in specialty drug cost management.

Kevin Mange, MD, MSCE, head of North America Medical Immunology at Sanofi, provides a comprehensive overview of the considerations in the treatment of rheumatoid arthritis, which carries comorbidities that affect multiple organ systems.

Cheryl Allen, vice president of Industry Relations at Diplomat Specialty Pharmacy, discusses the elements of an effective, high touch patient care program.

Patients with HIV can now expect to live into old age, and therefore need links to the community health network.

Sheila Arquette, RPh, discusses optimal patient support programs in specialty pharmacy.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from Specialty Pharmacy Times.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty pharmacists can help patients manage adverse events from their treatment regimen.

The shifting landscape in specialty dispensing among pharmacies that service patients in senior care settings and long-term care facilities.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies help advance the goals of accountable care organizations.

Eric Peacock, CEO of MyHealthTeams, discusses effective treatment of patients with chronic conditions.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses how the needs of specialty pharmacy, payers, and manufacturers can be aligned.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses high drug costs and the specialty pharmacy patient.

Exclusive, limited, and open networks each have pros and cons that must be weighed heavily.

Cutting supply of essential nutrients restrains tumors.

Rinku A. Patel, PharmD, RPh, discusses how to improve communication among patients, physicians, pharmacists, and payers.

Interstitial lung disease, a common complication of rheumatoid arthritis, often leads to deteriorating health.

The transition to value-based reimbursement is likely to shape the future of health care.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can best position themselves to access limited distribution drugs.

Stakeholders across the care landscape, including long-term care pharmacies, specialty pharmacies, and home infusion pharmacies, gather to discuss challenges and opportunities.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses how specialty pharmacies can help patients gain access to costly specialty drug regimens.

Study finds drug prices have been both increasing and decreasing for prescription drugs, independent of rebates.

Rebekah L. Hanson, PharmD, BCPS, BCACP, discusses the elements of an effective patient management program in specialty pharmacy.

Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how pharmacies can help patients manage high drug costs.

Patient engagement and involvement found to be crucial to in effective rheumatoid arthritis treatment.

For more than a half-century now, we’ve been debating who should pay for health care: patients, consumers, employers, taxpayers, or charities?

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of specialty therapies.

FDA requires additional clinical data to determine the most appropriate doses of Olumiant (baricitinib) for the treatment of rheumatoid arthritis (RA).